Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Debra Friedman

8 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    COGANHL04B1

    09/14/2006

    Rare and Cutaneous Non-Hodgkin Lymphoma Registry

    Health Services Research

    VICCNCPED1513

    08/28/2015

    An Observational, Multi-Center Study to Evaluate the Safety of Deferasirox in the Treatment of Pediatric Patients with Non-Transfusion-Dependent Iron Overload

    Health Services Research

    VICCREACH1447

    04/16/2014

    Retinoblastoma Survivor Study (RBSS)

    Other

    COGALTE11C1

    08/21/2013

    ALTE11C1 - Longitudinal Assessment of Ovarian Reserve in Adolescents with Lymphoma

    Other

    COGALTE03N1

    04/20/2005

    Key Adverse Events after Childhood Cancer

    Supportive Care

    VICCREACH1525

    05/11/2015

    Navigated Early Survivorship Transition (NEST) Project

    Treatment

    COGAHOD1331

    07/15/2015

    A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

    Treatment

    COGAALL1231

    05/13/2015

    A Phase III Randomized Trial Investigating Bortezomib NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)


    Print this page for your doctor